Data on Testing Cancer Types

Select Solid Cancer Types 

The following data compilation of 667 patients from 22 peer reviewed published articles in select solid tumor types establish the positive predictive accuracy of cell death assays at 78.8 percent and negative predictive accuracy of 90.1 percent. This breakdown reveals compelling evidence that assay directed therapies could improve response rates, time to progression and survival.

View Select Solid Cancer Type Table

Hematologic (Blood) Cancer Types

The following data compilation of 1181 patients from 23 peer reviewed published articles in select hematologic tumor types establish the positive predictive accuracy of cell death assays at 81.8 percent and negative predictive accuracies of 83.3 percent. This breakdown reveals compelling evidence that assay directed therapies could improve response rates, time to progression and survival.

View Hematologic (Blood) Cancer Type Table

Gynecologic Cancer Types

The following data compilation of 345 patients from 11 peer reviewed published articles in ovarian tumors establish the positive predictive accuracy of cell death assays at 77.0 percent and negative predictive accuracies of 87.9 percent. This breakdown reveals compelling evidence that assay directed therapies could improve response rates, time to progression and survival.

View Gynecologic Cancer Type Table

 

INFOGRAPHIC

How We Test Your Cancer

Currently, hundreds of drugs, drug combinations and targeted agents are used to treat cancer patients. With so many choices, how does your oncologist decide which ones are right for you?